DC Advisory advised Gada Group on the acquisition of Evoluzione

Background 

  • Gada Group (Gada) is a leading distributor of medical devices for cardiovascular, blood management and intensive care and is an experienced provider of integrated healthcare services 
  • Gada has been working for over 40 years with both public and private hospitals in Italy, having developed long-term partnerships with key international medical device suppliers
  • Evoluzione is an Italian distributor of specialist medical devices - both third party and proprietary - offering a vast range of niche products that are designed to prevent complications in intravenous and intra-arterial therapies 

Process

  • DC Advisory (DC) was engaged by Gada in April 2021 to advise on the acquisition of Evoluzione 
  • Throughout the process, DC supported Gada across multiple different work streams, including:  
    • Valuation and deal structuring;
    • Process strategy and tactics;
    • Assistance with contract negotiations; 
    • Support with transaction financing; and 
    • Process management

Outcome

  • Following a detailed due diligence process, the sale and purchase agreement was signed on 22 October 2021 
  • The acquisition of Evoluzione is expected to:
    • Expand Gada's offering through complementary products that will create vast upselling potential;
    • Exploit synergies from both a distribution channel and product portfolio perspective; 
    • Create a partnership of the two commercial structures 
  • The transaction closed on 29 October 2021

"We greatly appreciate DC Advisory’s support on this important transaction for us. In particular, they provided valuable advice on the deal structuring, which tightly links the purchase price to the future performance of the acquired business. They have also assisted us throughout the process, ultimately bringing the deal to the finish line.”

Luisa Salza
CFO, Gada Group

"It has been a pleasure to assist Gada Group - an important client for DC - in this strategic step that will help them accelerate their growth trajectory and enhance their product offering. For DC, this is a further example of our strong capabilities and expertise in the healthcare space.”

Giuliano Guarino
Managing Director, DC Advisory
Date
Sectors
  • Healthcare
Deal type
  • M&A Advisory
Deal locations
Italy
Deal team
Co-Head of Italy
UN SDG Activity
  • GOAL 3: Good Health and Well-being

Disclaimer

For more information, please see our transaction disclaimer

For important information regarding testimonials, please see our disclaimer.

Contact form

Thank you!

Your message has been received by DC Advisory so you'll hear back from us soon.

We collect your personal data if you sign up to receive news or get in touch with us. This is collected by third-party firms on our behalf. We have three separate lists:

  1. DealCloud - which we use as our CRM. DealCloud privacy statement is available here: https://www.intapp.com/privacy/
  2. SalesForce - which we use as our CRM. SalesForce privacy statement is available here: https://www.salesforce.com/uk/company/privacy/
  3. Spotler - which we use to send email marketing campaigns. Spotler privacy statement is available here: https://spotler.co.uk/privacy-policy/

Application form

Application documents*
(Maximum file size of 10 MB. File types accepted: pdf or doc)
* Compulsory fields

Thank you!

Your message has been received by DC Advisory so you'll hear back from us soon.

Back to top